2023 NEJM Phase 2 obesity trial used a starting dose of 2 mg once weekly with dose escalation every 4 weeks, reaching a maximum tested maintenance dose of 12 mg/week [1][2]
2024 Biomolecules review, suggests that GLP-1 agonists do not have a direct toxic effect on thyroid cells
Retatrutide vs Tirzepatide: Head-to-Head Comparison Table Weight Loss Efficacy: The Numbers Tell the Story The most significant data point in the retatrutide vs tirzepatide debate is the magnitude of weight loss
Go urgently for severe abdominal pain, trouble breathing, facial swelling, persistent vomiting, or signs of dehydration
As your body adjusts and these effects fade, caloric consumption can creep upward without conscious awareness
LDL cholesterol (often called 'bad cholesterol') and total cholesterol also tend to decrease in semaglutide users, though the magnitude varies